Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

Ioannis Parodis, Julius Lindblom, Roger A. Levy, Margherita Zen, Nurşen Çetrez, Alvaro Gómez, Shereen Oon, Christine Henning, Munther A. Khamashta, Holly Quasny, Deven Chauhan, Anca Askanase, Ronald van Vollenhoven, Mandana Nikpour